Labeler
Exelan Pharmaceuticals Inc. NDC Codes
Exelan Pharmaceuticals Inc. lists 175 finished drug products in the FDA NDC Directory under NDC labeler code 76282.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Pregabalin, Lenalidomide, Lisinopril, Brivaracetam, Lurasidone Hydrochloride, Oseltamivir Phosphate, Topiramate, Metoprolol Tartrate, Nicotine Transdermal System, Lanreotide Acetate, Bumetanide, Dofetilide, Vilazodone Hydrochloride, Pirfenidone, Sildenafil
- Active ingredients
- Lisinopril, Pregabalin, Lenalidomide, Brivaracetam, Lurasidone hydrochloride, Oseltamivir phosphate, Topiramate, Metoprolol tartrate, Nicotine, Lanreotide acetate, Bumetanide, Dofetilide
- NDC labeler codes
- 76282
- Strengths (from the 100 most recently listed products)
- Lisinopril 10 mg/1; Lisinopril 20 mg/1; Pirfenidone 267 mg/1; Hydrochlorothiazide 12.5 mg/1; Paclitaxel 100 mg/20mL; Brivaracetam 10 mg/1; Brivaracetam 25 mg/1; Brivaracetam 50 mg/1; Brivaracetam 75 mg/1; Brivaracetam 100 mg/1; Tofacitinib citrate 11 mg/1; Nintedanib esylate 100 mg/1; Nintedanib esylate 150 mg/1; Metoprolol tartrate 25 mg/1; Metoprolol tartrate 50 mg/1; Metoprolol tartrate 100 mg/1; Ticagrelor 60 mg/1; Nicotine 7 mg/24h; Nicotine 14 mg/24h; Nicotine 21 mg/24h
- Dosage forms
- Tablet, Capsule, Tablet, Film coated, Film, Extended release, Injection, Tablet, Chewable, Tablet, Coated, Injection, Powder, Lyophilized, For suspension, Tablet, Film coated, Extended release, Gel, For suspension, Inhalant
- Routes
- Oral, Transdermal, Subcutaneous, Intravenous, Topical, Respiratory (Inhalation)
- Drug classes (FDA established)
- Angiotensin Converting Enzyme Inhibitor, beta-Adrenergic Blocker, Thalidomide Analog, Atypical Antipsychotic, Nonsteroidal Anti-inflammatory Drug, Neuraminidase Inhibitor, Cholinergic Nicotinic Agonist, Somatostatin Analog, Loop Diuretic, Antiarrhythmic, Pyridone, Phosphodiesterase 5 Inhibitor, Dihydropyridine Calcium Channel Blocker, Phosphate Binder, Calcium-sensing Receptor Agonist, Kinase Inhibitor, P2Y12 Platelet Inhibitor, Protease Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-epileptic Agent, Bisphosphonate, Thiazide Diuretic, Microtubule Inhibitor, Janus Kinase Inhibitor, Factor Xa Inhibitor, Muscle Relaxant, alpha-Adrenergic Blocker, Vitamin K, Warfarin Reversal Agent, beta2-Adrenergic Agonist, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 190 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Paclitaxel 100mg per vialpaclitaxel protein-bound particles | Paclitaxel 100 mg/20mL | Injection, Powder, Lyophilized, For suspensionIntravenous | 76282-768 | 76282-0768-09 | — |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | 76282-822 | — | — |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | 76282-823 | — | — |
| Brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | 76282-824 | — | — |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | 76282-825 | — | — |
| Brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | 76282-826 | — | — |
| Tofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | 76282-816 | 76282-0816-30 | — |
| Nintedanib Capsules, 100 mg and 150 mgnintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | 76282-786 | 76282-0786-60 | — |
| Nintedanib Capsules, 100 mg and 150 mgnintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | 76282-787 | 76282-0787-60 | — |
| Metoprolol Tartrate | Metoprolol tartrate 25 mg/1 | TabletOral | 76282-794 | 76282-0794-0176282-0794-10 | — |
| Metoprolol Tartrate | Metoprolol tartrate 50 mg/1 | TabletOral | 76282-795 | 76282-0795-0176282-0795-10 | — |
| Metoprolol Tartrate | Metoprolol tartrate 100 mg/1 | TabletOral | 76282-796 | 76282-0796-0176282-0796-10 | — |
| Ticagrelor | Ticagrelor 60 mg/1 | Tablet, Film coatedOral | 76282-584 | 76282-0584-0176282-0584-0576282-0584-60 | — |
| Nicotine Transdermal Systemnicotine | Nicotine 7 mg/24h | Film, Extended releaseTransdermal | 76282-781 | 76282-0781-40 | — |
| Nicotine Transdermal Systemnicotine | Nicotine 14 mg/24h | Film, Extended releaseTransdermal | 76282-782 | 76282-0782-40 | — |
| Nicotine Transdermal Systemnicotine | Nicotine 21 mg/24h | Film, Extended releaseTransdermal | 76282-783 | 76282-0783-40 | — |
| Rivaroxaban | Rivaroxaban 2.5 mg/1 | Tablet, Film coatedOral | 76282-774 | 76282-0774-1876282-0774-60 | — |
| Lanreotide Acetate | Lanreotide acetate 60 mg/.2mL | InjectionSubcutaneous | 76282-718 | 76282-0718-67 | — |
| Lanreotide Acetate | Lanreotide acetate 90 mg/.3mL | InjectionSubcutaneous | 76282-719 | 76282-0719-67 | — |
| Lanreotide Acetate | Lanreotide acetate 120 mg/.5mL | InjectionSubcutaneous | 76282-720 | 76282-0720-67 | — |
| Ticagrelor | Ticagrelor 90 mg/1 | Tablet, Film coatedOral | 76282-550 | 76282-0550-0176282-0550-0576282-0550-60 | — |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | TabletOral | 76282-283 | 76282-0283-1076282-0283-1876282-0283-27+3 more | — |
| Bumetanide | Bumetanide .5 mg/1 | TabletOral | 76282-797 | 76282-0797-01 | — |
| Bumetanide | Bumetanide 1 mg/1 | TabletOral | 76282-798 | 76282-0798-0176282-0798-05 | — |
| Bumetanide | Bumetanide 2 mg/1 | TabletOral | 76282-799 | 76282-0799-0176282-0799-05 | — |
| Dofetilide | Dofetilide .125 mg/1 | CapsuleOral | 76282-755 | 76282-0755-60 | — |
| Dofetilide | Dofetilide .25 mg/1 | CapsuleOral | 76282-756 | 76282-0756-60 | — |
| Dofetilide | Dofetilide .5 mg/1 | CapsuleOral | 76282-757 | 76282-0757-60 | — |
| Diclofenac Sodium | Diclofenac sodium 10 mg/g | GelTopical | 76282-103 | 76282-0103-39 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 76282-696 | 76282-0696-48 | — |
| lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 76282-700 | 76282-0700-47 | — |
| Tamsulosin hydrochloride | Tamsulosin hydrochloride .4 mg/1 | CapsuleOral | 76282-744 | 76282-0744-0576282-0744-90 | — |
| darunavirdarunavir 600 mg | Darunavir hydrate 600 mg/1 | TabletOral | 76282-737 | 76282-0737-60 | — |
| darunavirdarunavir 800 mg | Darunavir hydrate 800 mg/1 | TabletOral | 76282-738 | 76282-0738-30 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 30 mg/1 | CapsuleOral | 76282-702 | 76282-0702-45 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 45 mg/1 | CapsuleOral | 76282-703 | 76282-0703-45 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 75 mg/1 | CapsuleOral | 76282-704 | 76282-0704-45 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 6 mg/mL | For suspensionOral | 76282-739 | 76282-0739-52 | — |
| Phytonadione | Phytonadione 5 mg/1 | TabletOral | 76282-740 | 76282-0740-30 | — |
| Lisinopril | Lisinopril 2.5 mg/1 | TabletOral | 76282-728 | 76282-0728-0176282-0728-0576282-0728-10+4 more | — |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | 76282-729 | 76282-0729-0176282-0729-0576282-0729-10+4 more | — |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | 76282-730 | 76282-0730-0176282-0730-0576282-0730-10+5 more | — |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | 76282-731 | 76282-0731-0176282-0731-0576282-0731-10+5 more | — |
| Lisinopril | Lisinopril 30 mg/1 | TabletOral | 76282-732 | 76282-0732-0176282-0732-0576282-0732-10+4 more | — |
| Lisinopril | Lisinopril 40 mg/1 | TabletOral | 76282-733 | 76282-0733-0176282-0733-0576282-0733-10+4 more | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | 76282-522 | 76282-0522-30 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | 76282-523 | 76282-0523-30 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | 76282-524 | 76282-0524-30 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, Film coatedOral | 76282-525 | 76282-0525-30 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | 76282-534 | 76282-0534-30 | — |
Exelan Pharmaceuticals Inc.: common questions
- What is Exelan Pharmaceuticals Inc.'s NDC labeler code?
- 76282. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Exelan Pharmaceuticals Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.